|
1
|
McGuire S: World Cancer Report 2014.
Geneva, Switzerland: World Health Organization, International
Agency for Research on Cancer, WHO Press, 2015. Adv Nutr.
7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crosbie EJ, Einstein MH, Franceschi S and
Kitchener HC: Human papillomavirus and cervical cancer. Lancet.
382:889–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi YJ and Park JS: Clinical significance
of human papillomavirus genotyping. J Gynecol Oncol. 27:e212016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Groves IJ and Coleman N: Pathogenesis of
human papillomavirus-associated mucosal disease. J Pathol.
235:527–538. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gravitt PE: The known unknowns of HPV
natural history. J Clin Invest. 121:4593–4599. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yugawa T and Kiyono T: Molecular
mechanisms of cervical carcinogenesis by high-risk human
papillomaviruses: Novel functions of E6 and E7 oncoproteins. Rev
Med Virol. 19:97–113. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rashid NN, Rothan HA and Yusoff MS: The
association of mammalian DREAM complex and HPV16 E7 proteins. Am J
Cancer Res. 5:3525–3533. 2015.PubMed/NCBI
|
|
8
|
Egawa N, Egawa K, Griffin H and Doorbar J:
Human papillomaviruses; epithelial tropisms, and the development of
neoplasia. Viruses. 7:3863–3890. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saslow D, Solomon D, Lawson HW, Killackey
M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur
DC, et al: American Cancer Society, American Society for Colposcopy
and Cervical Pathology, and American Society for Clinical Pathology
screening guidelines for the prevention and early detection of
cervical cancer. Am J Clin Pathol. 137:516–542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goodman A: HPV testing as a screen for
cervical cancer. BMJ. 350:h23722015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dasari S, Wudayagiri R and Valluru L:
Cervical cancer: Biomarkers for diagnosis and treatment. Clin Chim
Acta. 445:7–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stiasny A, Kuhn C, Mayr D, Alexiou C,
Janko C, Wiest I, Jeschke U and Kost B: Immunohistochemical
evaluation of E6/E7 HPV oncoproteins staining in cervical cancer.
Anticancer Res. 36:3195–3198. 2016.PubMed/NCBI
|
|
13
|
Hoffmann A and Roeder RG: Purification of
his-tagged proteins in non-denaturing conditions suggests a
convenient method for protein interaction studies. Nucleic Acids
Res. 19:6337–6338. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harper S and Speicher DW: Purification of
proteins fused to glutathione S-transferase. Methods Mol Biol.
681:259–280. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morbini P, Alberizzi P, Tinelli C, Paglino
C, Bertino G, Comoli P, Pedrazzoli P and Benazzo M: Identification
of transcriptionally active HPV infection in formalin-fixed,
paraffin-embedded biopsies of oropharyngeal carcinoma. Hum Pathol.
46:681–689. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pirog EC: Immunohistochemistry and in situ
hybridization for the diagnosis and classification of squamous
lesions of the anogenital region. Semin Diagn Pathol. 32:409–418.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Szarewski A, Mesher D, Cadman L, Austin J,
Ashdown-Barr L, Ho L, Terry G, Liddle S, Young M, Stoler M, et al:
Comparison of seven tests for high-grade cervical intraepithelial
neoplasia in women with abnomal smears: The predictors 2 study. J
Clin Microbiol. 50:1867–1873. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lidqvist M, Nilsson O, Holmgren J, Hölters
S, Röijer E, Dürst M and Fermér C: Detection of human
papillomavirus oncoprotein E7 in liquid-based cytology. J Gen
Virol. 93:356–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marks JD and Bradbury A: PCR cloning of
human immunoglobulin genes. Methods Mol Biol. 248:117–134.
2004.PubMed/NCBI
|
|
20
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, et
al: The 2001 Bethesda System: Terminology for reporting results of
cervical cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szalmás A, Tomaić V, Basukala O, Massimi
P, Mittal S, Kónya J and Banks L: The PTPN14 tumor suppressor is a
degradation target of human papillomavirus E7. J Virol.
91:e00057–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nanda K, McCrory DC, Myers ER, Bastian LA,
Hasselblad V, Hickey JD and Matchar DB: Accuracy of the
Papanicolaou test in screening for and follow-up of cervical
cytologic abnormalities: A systematic review. Ann Intern Med.
132:810–819. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Katki HA, Kinney WK, Fetterman B, Lorey T,
Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S and Castle
PE: Cervical cancer risk for women undergoing concurrent testing
for human papillomavirus and cervical cytology: A population-based
study in routine clinical practice. Lancet Oncol. 12:663–672. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zazove P, Reed BD, Gregoire L, Ferenczy A,
Gorenflo DW and Lancaster WD: Low false-negative rate of PCR
analysis for detecting human papillomavirus-related cervical
lesions. J Clin Microbiol. 36:2708–2713. 1998.PubMed/NCBI
|
|
26
|
Faoro V, Barbazza R, Bonin S, Brunetti D,
Sulfaro S and Stanta G: Detection of HPV E7 oncoviral protein in
cervical lesions by a new antibody. Appl Immunohistochem Mol
Morphol. 21:341–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ramirez N, Guerra F, Camporeale G,
Quintana S, Diaz LB, Cuneo N, Villacorta Hidalgo J, Tatti SA,
Alonso LG, Borkosky SS, et al: Expressions of E2 and E7-HPV16
proteins in pre-malignant and malignant lesions of the uterine
cervix. Biotech Histochem. 90:573–580. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arbyn M, Paraskevaidis E, Martin-Hirsch P,
Prendiville W and Dillner J: Clinical utility of HPV-DNA detection:
Triage of minor cervical lesions, follow-up of women treated for
high-grade CIN: An update of pooled evidence. Gynecol Oncol. 99 3
Suppl 1:S7–S11. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nasiell K, Roger V and Nasiell M: Behavior
of mild cervical dysplasia during long term follow-up. Obstet
Gynecol. 67:665–669. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Holowaty P, Miller AB, Rohan T and To T:
Natural history of dysplasia of the uterine cervix. J Natl Cancer
Inst. 91:252–258. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
van Bogaert LJ: P16INK4a
immunocytochemistry/immunohistochemistry: Need for scoring
uniformization to be clinically useful in gynecological pathology.
Ann Diagn Pathol. 16:422–426. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dantur K, Alonso L, Castaño E, Morelli L,
Centeno-Crowley JM, Vighi S and de Prat-Gay G: Cytosolic
accumulation of HPV16 E7 oligomers supports different
transformation routes for the prototypic viral oncoprotein: The
amyloid-cancer connection. Int J Cancer. 125:1902–1911. 2009.
View Article : Google Scholar : PubMed/NCBI
|
